Search results
Thyrotoxicosis is relatively common among pregnant women and women of childbearing age. Overt persis-tent hyperthyroidism in women of childbearing age most frequently is caused by Graves disease (GD), which affects 0.4 to 1.0% of women in the preconception period and about 0.2% of women during pregnancy (1,2).
1 gru 2014 · Thyrotoxicosis of pregnancy can present unique diagnostic challenges and, if untreated, is associated with increased risks of adverse maternal, fetal, and neonatal complications.
Thyroid diseases are the commonest cause of endocrine dysfunction in women of childbearing age and, therefore, encountered commonly in pregnancy. Disorders of thyroid hormone production and their treatment can affect fertility, maternal well-being, fetal growth and development.
1 kwi 2013 · PDF | On Apr 1, 2013, Małgorzata Gietka-Czernel published Thyrotoxicosis and pregnancy | Find, read and cite all the research you need on ResearchGate.
This review provides a summary of the differential diagnosis, clinical presentation, diagnostic options, potential adverse effects of maternal thyrotoxicosis to the fetus, and treatment recommendations for thyrotoxicosis arising in pregnancy.
1 sie 2022 · During pregnancy, thyrotoxicosis can entail maternal, obstetrical and fetal or neonatal complications. Graves’ hyperthyroidism may be responsible for fetal and neonatal hyperthyroidism due to placental transfer of stimulatory anti-TSH receptor antibodies.
5 kwi 2013 · Thyrotoxicosis affects 1-3.5% of all pregnancies and its major cause is gestational hyperthyroidism and Graves’ disease, less common – multinodular toxic goiter and toxic adenoma, and rare – subacute or silent thyroiditis and struma ovarii.
